Takeda Pharma Sp. z o.o. secures contract for Pharmaceutical Products - a medicinal product of human immunoglobulin normal recombinant hyaluronidase. Human hyaluronidase set of drug accessories; subcutaneous application

Poland, Sept. 8 -- Poland based Takeda Pharma Sp. z o.o. has secured contract from UNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU for Pharmaceutical Products - a medicinal product of human immunoglobulin normal recombinant hyaluronidase. Human hyaluronidase set of drug accessories; subcutaneous application. The value of the contract is worth 73034000 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....